Neurosurgical and Neuroendovascular Management of Takayasu's Arteritis

医学 动脉炎 外科 血运重建 灌注 血管内治疗 大动脉炎 放射科 大动脉炎 锁骨下动脉 血管炎 心脏病学 内科学 动脉瘤 疾病 心肌梗塞
作者
Marcus A. Stoodley,Reid C. Thompson,R. Scott Mitchell,Michael P. Marks,Gary K. Steinberg
出处
期刊:Neurosurgery [Oxford University Press]
卷期号:46 (4): 841-852 被引量:5
标识
DOI:10.1097/00006123-200004000-00014
摘要

The roles of surgical and endovascular treatments for patients with Takayasu's arteritis are not clear. We report our experience in the neurosurgical and/or neuroendovascular treatment of patients with Takayasu's arteritis who exhibited ischemic neurological symptoms.Between 1994 and 1998, seven patients with Takayasu's arteritis and neurological symptoms were treated at the Stanford University Medical Center. All patients were angiographically evaluated and received maximal medical therapy. Cerebral blood flow studies were performed for six patients. Three patients underwent surgical revascularization procedures alone, two underwent combinations of surgical and endovascular procedures, and two underwent endovascular treatment alone.The most common neurological symptoms were dysequilibrium, syncope, and visual disturbances. The characteristic angiographic features of Takayasu's arteritis were identified for all patients. The subclavian arteries and proximal carotid and vertebral arteries were involved in all patients. Two patients exhibited improvement of their symptoms after endovascular treatment alone. There were two deaths after surgery, involving patients with severe global cerebral hypoperfusion. All other surgically treated patients exhibited improvement of their symptoms, with patent grafts, up to 4 years after surgery. Cerebral blood flow improved after treatment.Improvement of symptoms can be achieved with surgical revascularization and/or endovascular treatment. Staged revascularization might be better than one-stage bilateral high-flow grafting for patients with severe global hypoperfusion.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cbyyy发布了新的文献求助20
1秒前
桥墩墩完成签到,获得积分10
1秒前
PLA完成签到,获得积分10
2秒前
Hey完成签到 ,获得积分10
3秒前
果汁橡皮糖完成签到,获得积分10
3秒前
Jasper应助阳光铭媚采纳,获得10
3秒前
薛硕发布了新的文献求助10
3秒前
yanmh完成签到,获得积分10
3秒前
Saint完成签到,获得积分10
4秒前
诚心的海白完成签到 ,获得积分10
6秒前
chendahuanhuan完成签到,获得积分10
6秒前
orixero应助咯咚采纳,获得10
6秒前
gjy完成签到,获得积分10
6秒前
研友_VZG7GZ应助星夜采纳,获得10
7秒前
momoni完成签到 ,获得积分10
8秒前
10秒前
10秒前
yy完成签到,获得积分10
10秒前
JamesPei应助高高采纳,获得10
11秒前
冷傲的绿蓉完成签到,获得积分10
11秒前
GB完成签到 ,获得积分10
11秒前
内向乾完成签到,获得积分10
12秒前
科研通AI2S应助天真千易采纳,获得10
12秒前
12秒前
LL完成签到,获得积分10
13秒前
13秒前
dildil完成签到,获得积分10
13秒前
开心的尔竹完成签到,获得积分10
14秒前
14秒前
orixero应助swing采纳,获得10
14秒前
17秒前
共享精神应助moonpie采纳,获得10
17秒前
Gabriel发布了新的文献求助10
18秒前
科研通AI2S应助冰阔落采纳,获得10
19秒前
坚定的藏花完成签到,获得积分10
19秒前
干净的琦应助含蓄访天采纳,获得30
19秒前
20秒前
20秒前
愉快乐瑶发布了新的文献求助10
20秒前
在水一方应助蜀葵采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6029099
求助须知:如何正确求助?哪些是违规求助? 7697622
关于积分的说明 16189004
捐赠科研通 5176274
什么是DOI,文献DOI怎么找? 2770004
邀请新用户注册赠送积分活动 1753368
关于科研通互助平台的介绍 1639089